サンプル依頼リスト カート
  • English
表紙：経口臨床栄養市場-世界の産業規模、シェア、動向、機会、予測、2018-2028年
市場調査レポート
商品コード
1331402

経口臨床栄養市場-世界の産業規模、シェア、動向、機会、予測、2018-2028年

Oral Clinical Nutrition Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Indication, By Distribution Channel, Region and Competition
出版日: | 発行: TechSci Research | ページ情報: 英文 117 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円

こちらのレポートには、数時間（ご購入金額の10%）分のアナリストへの質問／追加調査サービスが含まれております。

経口臨床栄養市場-世界の産業規模、シェア、動向、機会、予測、2018-2028年
出版日: 2023年08月01日
発行: TechSci Research
ページ情報: 英文 117 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 目次
概要

世界の経口臨床栄養市場は、慢性疾患の罹患率の上昇と患者中心のケアへの注目の高まりにより、予測期間中に目覚ましい成長を遂げる見通しです。

さらに、栄養不良やサルコペニア、悪液質などの関連疾患の有病率の増加も、製品に対する需要を促進しています。

患者中心のケアへの注目の高まり

患者中心のケアへの注目の高まりは、いくつかの点で世界の経口臨床栄養市場の成長に影響を与えています。患者中心のケアとは、患者をケアの中心に置き、個々のニーズや嗜好に合わせて治療計画を調整することに重点を置いたヘルスケア・アプローチです。このアプローチは、患者がより多くの情報に接し、ヘルスケアの意思決定において力を持つようになっていることから、ヘルスケアにおいてより一般的になってきています。

患者中心のケアへの注目の高まりは、個別化された栄養ソリューションへの需要を高め、品質と安全性の重要性を強調し、患者教育とサポートの必要性を強調することによって、世界の経口臨床栄養市場の成長を促進しています。

患者中心のケアは、個別化された栄養ソリューションに対する需要を増加させることにより、世界の経口臨床栄養市場の成長に影響を与えています。病状や栄養ニーズが異なる患者は、さまざまなタイプの栄養サポートを必要とします。例えば、がん患者は治療中の体重と筋肉量を維持するために高タンパク質・高カロリーの食事を必要とする場合があり、糖尿病患者は血糖値をコントロールするために低糖質の食事を必要とする場合があります。患者がヘルスケアに関する知識を深め、より個別化されたケアを求めるようになるにつれて、特定の栄養ニーズに対応できる経口臨床栄養製品に対するニーズが高まっています。

患者中心のケアは、経口栄養製品の品質と安全性を重視するようになり、経口臨床栄養市場の成長を促進しています。患者は、栄養不良、脱水、消化管合併症など、栄養不良に伴うリスクをより強く認識するようになっています。その結果、健康維持に役立つ高品質で安全な経口栄養製品が求められるようになっています。安全で効果的な経口臨床栄養製品に対するこのような需要は、業界の技術革新の原動力となっており、各社はさまざまな病状の患者のニーズを満たす新しい製剤や改良された製剤を開発しています。

患者中心のケアは、患者教育とサポートの重要性を高めることにより、世界の経口臨床栄養市場の成長に影響を与えています。経口臨床栄養製品の投与を受ける患者は、その製品を正しく効果的に使用する方法について教育を受ける必要があります。これには、経口栄養製剤を日常生活にどのように取り入れるか、どのように調製・投与するか、どのように栄養状態をモニタリングするかなどの指導が含まれます。患者はまた、栄養目標を確実に達成し、健康を維持するために、継続的なサポートとモニタリングも必要とします。その結果、このような教育とサポートを患者に提供できるヘルスケア専門家に対するニーズが高まっており、これが世界の経口臨床栄養市場の成長を牽引しています。

栄養不良およびその他の関連疾患の有病率の増加

栄養不良および関連疾患の有病率の増加は、世界の経口臨床栄養市場の成長を促進する主な要因の1つです。栄養不良は体内の必須栄養素の不足によって引き起こされる状態で、免疫系の弱体化、創傷治癒の遅れ、成長と発育の障害など、さまざまな健康問題につながる可能性があります。栄養不良は、がん、HIV/AIDS、糖尿病などの慢性疾患を持つ患者に特に多く、これらの疾患は栄養素の吸収・利用能力に影響を及ぼすためです。

慢性疾患の発生率が世界的に上昇し続けているため、経口臨床栄養製品に対する需要も増加しています。特殊な経腸栄養剤やサプリメントなどの経口臨床栄養製品は、栄養不良やその他の関連疾患を持つ患者が通常の食事では摂取できない可能性のある必須栄養素を提供するために設計されています。

栄養不良および関連疾患の有病率の増加は、患者中心のケアへの関心の高まりと革新的な栄養ソリューションの利用可能性と相まって、世界の経口臨床栄養市場の成長を促進しています。

利用可能なカスタマイズ：

TechSci Research社は、所定の市場データを用いて、企業固有のニーズに応じたカスタマイズを提供しています。レポートでは以下のカスタマイズが可能です：

企業情報

  • 追加市場参入企業（最大5社）の詳細分析とプロファイリング

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の経口臨床栄養市場の展望

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 適応症別（アルツハイマー病、栄養不足、がん治療、慢性腎臓病、嚥下障害、その他）
    • 流通チャネル別（直販、間接販売）
    • 地域別
    • 企業別（2022年）
  • 製品マップ
    • 適応症別
    • 販売チャネル別
    • 地域別

第6章 北米の経口臨床栄養市場の展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • 適応症別
    • 流通チャネル別
    • 国別
  • 北米：国別分析
    • 米国
    • カナダ
    • メキシコ

第7章 欧州の経口臨床栄養市場の展望

  • 市場規模および予測
    • 金額別
  • 市場シェアと予測
    • 適応症別
    • 流通チャネル別
    • 国別
  • 欧州国別分析
    • フランス
    • ドイツ
    • 英国
    • イタリア
    • スペイン

第8章 アジア太平洋地域の経口臨床栄養市場の展望

  • 市場規模および予測
    • 金額別
  • 市場シェアと予測
    • 適応症別
    • 流通チャネル別
    • 国別
  • アジア太平洋地域国別分析
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア

第9章 南米の経口臨床栄養市場の展望

  • 市場規模および予測
    • 金額別
  • 市場シェアと予測
    • 適応症別
    • 流通チャネル別
    • 国別
  • 南米：国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第10章 中東・アフリカの経口臨床栄養市場の展望

  • 市場規模および予測
    • 金額別
  • 市場シェアと予測
    • 適応症別
    • 流通チャネル別
    • 国別
  • MEA：国別分析
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第11章 市場力学

  • 促進要因
  • 課題

第12章 市場動向と発展

  • 最近の展開
  • 合併・買収
  • 製品発表

第13章 世界の経口臨床栄養市場SWOT分析

第14章 ポーターのファイブフォース分析

  • 業界内の競合
  • 新規参入の可能性
  • サプライヤーの力
  • 顧客の力
  • 代替品の脅威

第15章 競合情勢

  • Business Overview
  • Service Offerings
  • Recent Developments
  • Key Personnel
  • SWOT Analysis
    • Abbott Laboratories, Inc.
    • Pfizer, Inc.
    • Bayer AG
    • Nestle SA
    • GlaxoSmithKline plc.
    • Baxter International Inc.
    • Otsuka Holdings, Co. Ltd.
    • Baxter International Inc.
    • Victus, Inc.
    • Danone SA（Nutricia）

第16章 戦略的提言

目次
Product Code: 15208

Global Oral Clinical Nutrition Market is poised to grow at an impressive rate during the forecast period on account of the rising incidence of chronic diseases and an increasing focus on patient-centric care. In addition, the growing prevalence of malnutrition and related conditions such as sarcopenia and cachexia are also fueling demand for the products.

Increasing demand for products that provide essential nutrients to patients who are unable to consume adequate amounts of food through normal means. This market encompasses a wide range of products, including supplements, enteral feeding formulas, and medical foods, all designed to provide patients with the nutrients they need to support their recovery and maintain their health.

One of the key drivers of the global oral clinical nutrition market is the increasing prevalence of chronic diseases, such as diabetes, cardiovascular disease, and cancer. These conditions can lead to malnutrition, which in turn can exacerbate the patient's health problems and increase the risk of complications. As a result, healthcare providers are increasingly turning to oral clinical nutrition products to help manage these conditions and improve patient outcomes.

Another key factor driving the oral clinical nutrition market is the aging population. As the population ages, the risk of malnutrition and related conditions increases, as does the need for products that can provide essential nutrients to support overall health and well-being. This has led to a growing demand for oral clinical nutrition products that are specifically designed for elderly patients, such as high-protein supplements and fortified meal replacements.

The market for oral clinical nutrition products is also being driven by a growing focus on patient-centric care. Healthcare providers are increasingly recognizing the importance of personalized nutrition in improving patient outcomes and are turning to oral clinical nutrition products to provide patients with the nutrients they need to support their recovery and maintain their health. This trend is also being driven by the rise of value-based care models, which prioritize patient outcomes and require healthcare providers to take a more holistic approach to patient care.

Oral clinical nutrition products are constantly evolving, with new products being developed and launched to meet the changing needs of patients and healthcare providers. Nestle Health Science launched Peptamen 100 ICU, a high-protein enteral formula specifically designed for critically ill patients, in 2019. The product contains a unique blend of whey and casein proteins, which are rapidly and slowly absorbed, respectively, providing sustained protein delivery to support muscle protein synthesis. Peptamen 100 ICU is also rich in antioxidants, which are essential for supporting the immune system and reducing oxidative stress.

Abbott launched Ensure Max Protein in 2020, a high-protein oral nutritional supplement designed to support muscle health and recovery. The product contains 30 grams of protein per serving, along with essential nutrients such as vitamins and minerals. It is available in three flavors and is designed for use as a snack or meal replacement.

Danone launched Nutricia Age Care in 2021, a range of specialized oral clinical nutrition products designed to meet the unique nutritional needs of elderly patients. The range includes products such as Fortimel Energy, a high-protein oral nutritional supplement, and FortiCare, a specialized enteral formula designed to support wound healing and recovery.

Patient compliance, cost, adverse effects, product availability, and nutritional adequacy are the factors that will hamper the growth of global oral clinical nutrition market in the forecast period.

One of the biggest challenges in global oral clinical nutrition market is patient compliance. Patients may find it difficult to adhere to strict dietary regimens or may have difficulty swallowing or digesting certain products. This can lead to inadequate nutrient intake and reduced effectiveness of the intervention. Healthcare providers must work closely with patients to ensure that they understand the importance of oral clinical nutrition and are able to comply with the prescribed treatment plan. Another challenge is the cost. These products can be expensive, and insurance coverage may be limited or nonexistent. This can make it difficult for patients to obtain the necessary products, especially if they require long-term use. Healthcare providers must work with patients and their families to explore options for financial assistance and insurance coverage.

Increasing Focus on Patient-Centric Care

The increasing focus on patient-centric care is influencing the growth of the global oral clinical nutrition market in several ways. Patient-centric care is a healthcare approach that focuses on putting the patient at the center of care and tailoring treatment plans to their individual needs and preferences. This approach is becoming more prevalent in healthcare as patients are becoming more informed and empowered in their healthcare decision-making.

The increasing focus on patient-centric care is driving the growth of the global oral clinical nutrition market by increasing the demand for personalized nutrition solutions, emphasizing the importance of quality and safety, and highlighting the need for patient education and support.

Patient-centric care is influencing the growth of the global oral clinical nutrition market by increasing the demand for personalized nutrition solutions. Patients with different medical conditions and nutritional needs require different types of nutritional support. For example, a patient with cancer may require a high-protein, high-calorie diet to maintain their weight and muscle mass during treatment, while a patient with diabetes may require a low-sugar diet to control their blood sugar levels. As patients become more informed about their healthcare and demand more personalized care, there is a growing need for oral clinical nutrition products that can be tailored to their specific nutritional needs.

Patient-centric care is driving the growth of the oral clinical nutrition market by increasing the emphasis on the quality and safety of oral nutrition products. Patients are becoming more aware of the risks associated with poor nutrition, such as malnutrition, dehydration, and gastrointestinal complications. As a result, they are demanding high-quality and safe oral nutrition products that can help them maintain their health and well-being. This demand for safe and effective oral clinical nutrition products is driving innovation in the industry, with companies developing new and improved formulations that meet the needs of patients with different medical conditions.

Patient-centric care is influencing the growth of the global oral clinical nutrition market by increasing the importance of patient education and support. Patients who receive oral clinical nutrition products need to be educated on how to use them correctly and effectively. This includes guidance on how to incorporate oral nutrition products into their daily routine, how to prepare and administer them, and how to monitor their nutritional status. Patients also require ongoing support and monitoring to ensure that they are achieving their nutritional goals and maintaining their health. As a result, there is a growing need for healthcare professionals who can provide this education and support to patients, which is driving the growth of the global oral clinical nutrition market.

Increasing Prevalence of Malnutrition and other related diseases

The increasing prevalence of malnutrition and related diseases is one of the key factors driving the growth of the global oral clinical nutrition market. Malnutrition is a condition caused by a lack of essential nutrients in the body, which can lead to a range of health problems, including weakened immune systems, slower wound healing, and impaired growth and development. Malnutrition is particularly prevalent in patients with chronic diseases, such as cancer, HIV/AIDS, and diabetes, as these conditions can affect the body's ability to absorb and utilize nutrients.

As the incidence of chronic diseases continues to rise globally, the demand for oral clinical nutrition products is increasing as well. Oral clinical nutrition products, such as specialized enteral formulas and supplements, are designed to provide the essential nutrients that patients with malnutrition or other related diseases may not be able to obtain through their regular diet.

The increasing prevalence of malnutrition and related diseases, coupled with a growing focus on patient-centric care and the availability of innovative nutrition solutions, is driving the growth of the global oral clinical nutrition market.

Market Segmentation

Global Oral Clinical Nutrition Market can be segmented by indication, distribution channel, region, and competitive landscape. Based on indication, the market can be divided into Alzheimer's, Nutritional Deficiencies, Cancer Care, Chronic Kidney Disease, Dysphagia, and Others. Based on distribution channels, the market is divided into Direct Sales and Indirect Sales. Regionally, the Oral Clinical Nutrition market can be categorized into North America, Europe, Asia Pacific, South America, and Middle East & Africa.

Market Players

Abbott Laboratories, Inc., Pfizer, Inc., Bayer AG, Nestle SA, GlaxoSmithKline plc., Baxter International Inc., Otsuka Holdings, Co. Ltd., Baxter International Inc., Victus, Inc., Danone SA(Nutricia), are some of the leading players operating in the Global Oral Clinical Nutrition Market.

Report Scope:

In this report, Global Oral Clinical Nutrition Market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Oral Clinical Nutrition Market, By Indication:

  • Alzheimer's
  • Nutritional Deficiencies
  • Cancer Care
  • Chronic Kidney Disease
  • Dysphagia
  • Others

Oral Clinical Nutrition Market, By Distribution Channel:

  • Direct Sales
  • Indirect Sales

Oral Clinical Nutrition Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Oral Clinical Nutrition Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validations
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Oral Clinical Nutrition Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Indication (Alzheimer's, Nutritional Deficiencies, Cancer Care, Chronic Kidney Disease, Dysphagia, Others)
    • 5.2.2. By Distribution Channel (Direct Sales v/s Indirect Sales)
    • 5.2.3. By Region
    • 5.2.4. By Company (2022)
  • 5.3. Product Map
    • 5.3.1. By Indication
    • 5.3.2. By Distribution Channel
    • 5.3.3. By Region

6. North America Oral Clinical Nutrition Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Indication
    • 6.2.2. By Distribution Channel
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Oral Clinical Nutrition Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Indication
        • 6.3.1.2.2. By Distribution Channel
    • 6.3.2. Canada Oral Clinical Nutrition Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Indication
        • 6.3.2.2.2. By Distribution Channel
    • 6.3.3. Mexico Oral Clinical Nutrition Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Indication
        • 6.3.3.2.2. By Distribution Channel

7. Europe Oral Clinical Nutrition Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Indication
    • 7.2.2. By Distribution Channel
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Oral Clinical Nutrition Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Indication
        • 7.3.1.2.2. By Distribution Channel
    • 7.3.2. Germany Oral Clinical Nutrition Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Indication
        • 7.3.2.2.2. By Distribution Channel
    • 7.3.3. United Kingdom Oral Clinical Nutrition Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Indication
        • 7.3.3.2.2. By Distribution Channel
    • 7.3.4. Italy Oral Clinical Nutrition Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Indication
        • 7.3.4.2.2. By Distribution Channel
    • 7.3.5. Spain Oral Clinical Nutrition Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Indication
        • 7.3.5.2.2. By Distribution Channel

8. Asia-Pacific Oral Clinical Nutrition Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Indication
    • 8.2.2. By Distribution Channel
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Oral Clinical Nutrition Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Indication
        • 8.3.1.2.2. By Distribution Channel
    • 8.3.2. India Oral Clinical Nutrition Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Indication
        • 8.3.2.2.2. By Distribution Channel
    • 8.3.3. Japan Oral Clinical Nutrition Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Indication
        • 8.3.3.2.2. By Distribution Channel
    • 8.3.4. South Korea Oral Clinical Nutrition Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Indication
        • 8.3.4.2.2. By Distribution Channel
    • 8.3.5. Australia Oral Clinical Nutrition Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Indication
        • 8.3.5.2.2. By Distribution Channel

9. South America Oral Clinical Nutrition Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Indication
    • 9.2.2. By Distribution Channel
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Oral Clinical Nutrition Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Indication
        • 9.3.1.2.2. By Distribution Channel
    • 9.3.2. Argentina Oral Clinical Nutrition Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Indication
        • 9.3.2.2.2. By Distribution Channel
    • 9.3.3. Colombia Oral Clinical Nutrition Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Indication
        • 9.3.3.2.2. By Distribution Channel

10. Middle East and Africa Oral Clinical Nutrition Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Indication
    • 10.2.2. By Distribution Channel
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Oral Clinical Nutrition Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Indication
        • 10.3.1.2.2. By Distribution Channel
    • 10.3.2. Saudi Arabia Oral Clinical Nutrition Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Indication
        • 10.3.2.2.2. By Distribution Channel
    • 10.3.3. UAE Oral Clinical Nutrition Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Indication
        • 10.3.3.2.2. By Distribution Channel

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global Oral Clinical Nutrition Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Service Offerings
  • 15.3. Recent Developments
  • 15.4. Key Personnel
  • 15.5. SWOT Analysis
    • 15.5.1. Abbott Laboratories, Inc.
    • 15.5.2. Pfizer, Inc.
    • 15.5.3. Bayer AG
    • 15.5.4. Nestle SA
    • 15.5.5. GlaxoSmithKline plc.
    • 15.5.6. Baxter International Inc.
    • 15.5.7. Otsuka Holdings, Co. Ltd.
    • 15.5.8. Baxter International Inc.
    • 15.5.9. Victus, Inc.
    • 15.5.10. Danone SA(Nutricia)

16. Strategic Recommendations